High detection rate of clinically relevant genomic abnormalities in plasma cells enriched from patients with multiple myeloma
- 25 July 2012
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 51 (11) , 997-1006
Abstract
Multiple myeloma is a heterogeneous disease, which is characterized by the occurrence of specific genomic abnormalities that are both of diagnostic and prognostic relevance. Since the detection of these abnormalities through molecular‐genetic techniques is hampered by the overall low percentage of plasma cells present in primary bone marrow aspirates, we assessed the efficacy of these techniques in enriched plasma cell fractions from 61 multiple myeloma patients. Using interphase FISH, genomic abnormalities could be detected in 96% of the enriched samples as compared to 61% in the cultured whole bone marrow samples. We also found that microarray‐based genomic profiling of enriched plasma samples facilitates the detection of additional, possibly clinically relevant, genomic abnormalities. We conclude that the genomic delineation of enriched plasma cells from multiple myeloma patients results in a significantly increased detection rate of clinically relevant genomic abnormalities. In order to facilitate molecular‐genetic data interpretation, we recommend morphological assessment of plasma cell purity after enrichment.Keywords
This publication has 26 references indexed in Scilit:
- Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trialsBlood, 2011
- Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)Journal of Clinical Oncology, 2010
- Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sortingInternational Journal of Hematology, 2010
- Prognostic Significance of Copy-Number Alterations in Multiple MyelomaJournal of Clinical Oncology, 2009
- A SNP microarray and FISH‐based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effectGenes, Chromosomes and Cancer, 2009
- Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern DenmarkCancer Genetics and Cytogenetics, 2007
- Association between Acquired Uniparental Disomy and Homozygous Gene Mutation in Acute Myeloid LeukemiasCancer Research, 2005
- Genetics and Cytogenetics of Multiple MyelomaCancer Research, 2004
- Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaLeukemia, 2003
- The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosisBlood, 1985